729 - A phase 2b, randomized, double-blinded, parallel-group, placebo-controlled, international, multicenter, study to evaluate the efficacy and safety of rezpegaldesleukin in adults with moderate-to-severe atopic dermatitisMelinda Gooderham, David Rosmarin, Craig A. Rohan et al.|British Journal of Dermatology|2024Cited by 2
724 - A phase 2b, randomized, double-blinded, parallel-group, placebo-controlled study to evaluate the efficacy and safety of rezpegaldesleukin in adults with severe to very-severe alopecia areataDavid Rosmarin, Charles Lynde, Neil S. Sadick et al.|British Journal of Dermatology|2024Cited by 0